Company Overview
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
Company Information
- CEO
- Richard Jon Barry
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 30
Contact Information
- Address
- 7801 North Capital of Texas Highway
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 112.56M market capitalization
- Trading Volume: 439.40K shares traded today
- Price Range: 52-week range of $1.15 - $33.98
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Cassava Sciences, Inc.
Cassava Sciences, Inc. (SAVA) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 112.56M, the company represents a significant player in its market. The stock is currently trading at $2.33 with a negativedaily change of 3.32%.
The company's 30 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -1.47, beta of -2.06, and 52-week price range from $1.15 to $33.98when evaluating investment opportunities.
Why Invest in Cassava Sciences, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Richard Jon Barry
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.